pioglitazone has been researched along with Carcinoma in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.
Excerpt | Relevance | Reference |
---|---|---|
"Pioglitazone was suspended for manufacture and sale by the Indian drug regulator in June 2013 due to its association with urinary bladder carcinoma, which was revoked within a short period (July 2013)." | 3.85 | Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study. ( Adhikari, A; Ambwani, S; Badyal, DK; Bairy, KL; Bhandare, B; Chakrabarti, A; Chandrashekar, K; Das, N; Dhamija, P; Dhasmana, DC; Goyal, A; Goyal, C; Gupta, YK; Jayanthi, CR; Kakkar, AK; Kaur, I; Kaushal, S; Kumar, R; Mazumdar, G; Munshi, R; Rehman, SU; Sarangi, SC; Sehgal, VK; Singh, H; Singh, J; Stephy, DJ; Thangaraju, P, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goyal, A | 1 |
Singh, H | 1 |
Sehgal, VK | 1 |
Jayanthi, CR | 1 |
Munshi, R | 1 |
Bairy, KL | 1 |
Kumar, R | 1 |
Kaushal, S | 1 |
Kakkar, AK | 1 |
Ambwani, S | 1 |
Goyal, C | 1 |
Mazumdar, G | 1 |
Adhikari, A | 1 |
Das, N | 1 |
Stephy, DJ | 1 |
Thangaraju, P | 1 |
Dhasmana, DC | 1 |
Rehman, SU | 1 |
Chakrabarti, A | 1 |
Bhandare, B | 1 |
Badyal, DK | 1 |
Kaur, I | 1 |
Chandrashekar, K | 1 |
Singh, J | 1 |
Dhamija, P | 1 |
Sarangi, SC | 1 |
Gupta, YK | 1 |
Antonelli, A | 1 |
Ferrari, SM | 1 |
Fallahi, P | 1 |
Berti, P | 1 |
Materazzi, G | 1 |
Minuto, M | 1 |
Giannini, R | 1 |
Marchetti, I | 1 |
Barani, L | 1 |
Basolo, F | 1 |
Ferrannini, E | 1 |
Miccoli, P | 1 |
Burton, JD | 1 |
Castillo, ME | 1 |
Goldenberg, DM | 1 |
Blumenthal, RD | 1 |
3 other studies available for pioglitazone and Carcinoma
Article | Year |
---|---|
Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study.
Topics: Adult; Aged; Carcinoma; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; India; Male; | 2017 |
Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells.
Topics: Carcinoma; Cell Proliferation; Growth Inhibitors; Humans; Pioglitazone; Rosiglitazone; Thiazolidined | 2009 |
Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
Topics: Anilides; Antineoplastic Agents; Apoptosis; Benzamides; Carcinoma; Caspase Inhibitors; Caspases; Cel | 2007 |